NCT03177824

Sildenafil Citrate for Treatment of Growth-restricted Fetuses

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Ain Shams University · Academic / Other
• Sex: Female
• Age: 20 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to assess the effect of Sildenafil citrate therapy on neonatal outcomes in women with fetal growth restriction.

Conditions

• Fetal Growth Restriction

Interventions

Type	Name	Description
DRUG	Sildenafil Citrate 25Mg Tab	Group 1, consists of 30 patients who will receive Sildenafil citrate (25mg) tab (Silden, Epico, Egypt) 3times daily till the time of delivery, followed by repeating the Doppler US scan serially to detect changes in the measured indices and then assess the neonatal outcome after delivery as regard birth weight and APGAR score.
DRUG	Placebo Oral Tablet	Group 2, consists of 30 patients receiving placebo Oral Tablet 3times daily , followed by repeating the Doppler US scan serially to detect changes in the measured indices and then assess the neonatal outcome after delivery as regard birth weight and APGAR score

Timeline

• Start date: 2017-03-30
• Primary completion: 2017-09-30
• Completion: 2017-10-01
• First posted: 2017-06-06
• Last updated: 2017-06-09

Locations

1 site across 1 country: Egypt